Maja Thiele
@majathiele.bsky.social
290 followers 82 following 11 posts
Professor of hepatology in Odense, Denmark. Biomarkers, fibrosis screening, MASLD, MetALD, ALD, stigma, omics technologies. Associate editor @JHEP_Reports - send me ALD manuscripts 🙏
Posts Media Videos Starter Packs
Pinned
majathiele.bsky.social
2024 marked a year of liver biomarker research #LiverSky

➡️Next 12 days I will post a summary of publications and collaborations, one month per day.

JANUARY:
Kicked off with a review on algorithms for early fibrosis detection, including the growing role of AI: www.thieme-connect.com/products/ejo...
majathiele.bsky.social
So nice to exchange ideas, celebrate the liver, and grow the community of #alcoholrelated liver disease research!
salve-liver.bsky.social
The SALVE group meeting in person to push research in ALD forward! Thanks to Carolin for arranging, we are looking forward to a productive day
@easlnews.bsky.social
Reposted by Maja Thiele
salve-liver.bsky.social
The SALVE group meeting in person to push research in ALD forward! Thanks to Carolin for arranging, we are looking forward to a productive day
@easlnews.bsky.social
majathiele.bsky.social
This is so far the most interesting article of 2025: The real-world leaky pipeline when screening for fibrosis and cirrhosis.

Less than 11% of VA patients with FIB-4≥3.25 could/would enter into elastography case finding program:
bmchealthservres.biomedcentral.com/articles/10....
majathiele.bsky.social
I recap 2024, month-by-month #LiverSky

🗓️MAY:
AASLD Practice Guidance on risk stratification & management of portal HT & varices in cirrhosis

👉From A to Z on 🔝 elastography and blood based NILTs

Read here👇
journals.lww.com/hep/fulltext...

@dougsimonetto.bsky.social @amergastroassn.bsky.social
majathiele.bsky.social
My #LiverSky recap of 2024

MARCH was kick-off month for
@liveraim.bsky.social ‼️
Learn more: liveraim.eu

LIVERAIM sets direction for biomarker research & implementation, including POSITIVE: the largest RCT in hepatology, with n=100,000
@aleksanderkrag.bsky.social @salvatore-piano.bsky.social
majathiele.bsky.social
Recap of 2024 for #LiverSky

📅FEBRUARY was omics month:
@jhepatology.bsky.social review on opportunities & barriers for omics as biomarkers

💪Powerful technologies which we are only now starting to explore in clinical care

🔗https://www.journal-of-hepatology.eu/article/S0168-8278(24)00219-8/fulltext
majathiele.bsky.social
Tak @majahorst.bsky.social - det betyder meget at en så garvet forsker & formidler som dig synes mine overvejelser var interessante!
majathiele.bsky.social
2024 marked a year of liver biomarker research #LiverSky

➡️Next 12 days I will post a summary of publications and collaborations, one month per day.

JANUARY:
Kicked off with a review on algorithms for early fibrosis detection, including the growing role of AI: www.thieme-connect.com/products/ejo...
majathiele.bsky.social
Thanks Atoosa - looking forward to exploring Bluesky + Liver
majathiele.bsky.social
The three critical rules of biomarker appraisal:

✋Truthful? = analytical validity
👍Meaningful? = clinical validity
🙌Useful? = clinical utility

youtu.be/zCjxDeyXgfU?...
#liversky #biomarkers #medicine
The three rules of biomarker appraisal
YouTube video by Maja Thiele
youtu.be
majathiele.bsky.social
Hi Peder - we're coming! Slow learners, but here now 👍